FrancophonIA/ELRC3.0 huggingface dataset:
English: • In some patients receiving infliximab, the body may not make enough of the blood cells that help fight infections or help stop bleeding.
Slovenian: • Pri nekaterih bolnikih, ki prejemajo zdravilo infliksimab, telo morda ne bo tvorilo dovolj krvnih celic, ki pomagajo v boju proti okužbam ali pri zaustavljanju krvavitve.
English: The interval between the last maintenance dose and the first reinduction dose ranged from 35-231 days.
Slovenian: Časovni razmik med zadnjim vzdrževalnim odmerkom zdravila in prvim odmerkom pri ponovni uporabi uvodne sheme je bil od 35 do 231 dni.
English: In this situation, do not return to refrigerated storage again.
Slovenian: V tem primeru ga ne smete shraniti nazaj v hladilnik.
English: Within the organ system classes, adverse reactions are listed under headings of frequency using the following categories: very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare (< 1/10,000), not known (cannot be estimated from the available data).
Slovenian: V okviru razvrstitve po organskih sistemih so neželeni učinki razvrščeni po naslednjih kategorijah pogostnosti: zelo pogosti (≥ 1/10), pogosti (≥ 1/100 do < 1/10), občasni (≥ 1/1000 do < 1/100), redki (≥ 1/10.000 do < 1/1.000), zelo redki (< 1/10.000), neznana pogostnost (pogostnosti iz razpoložljivih podatkov ni mogoče oceniti).
English: Median (Interquartile range) Patients with no deterioration/patients evaluated (%)
Slovenian: (interkvartilni razmik) bolniki brez poslabšanja/ pregledani bolniki (%)
English: Table 9 Effects on ACR and PASI in IMPACT and IMPACT 2
Slovenian: Preglednica 9 Učinki na ACR in PASI v študijah IMPACT in IMPACT 2
English: including bovine tuberculosis (disseminated BCG infection), see section 4.4
Slovenian: * vključno z bovino tuberkulozo (razsejano okužbo BCG), glejte poglavje 4.4
English: Do not use Flixabi if any of the above applies to you.
Slovenian: Ne uporabljajte zdravila Flixabi, če menite, da se katero od zgoraj navedenih stanj nanaša na vas.
English: • If you have had a break in your treatment with infliximab of more than 16 weeks, there is a higher risk for allergic reactions when you start the treatment again.
Slovenian: • Če ste prekinili zdravljenje z infliksimabom za več kot 16 tednov, obstaja večje tveganje za pojav alergijskih reakcij ob ponovni uvedbi zdravljenja.
English: • Abnormal values of a blood protein called ‘complement factor' which is part of the immune system.
Slovenian: • nenormalne vrednosti beljakovine v krvi, imenovane faktor komplementa, ki je del imunskega sistema.
English: The concomitant use of Flixabi with these biologics is not recommended because of the possibility of an increased risk of infection, and other potential pharmacological interactions.
Slovenian: Sočasne uporabe zdravila Flixabi s temi biološkimi zdravili ne priporočamo zaradi možnosti povečanega tveganja za okužbe in drugih možnih farmakoloških interakcij.
English: If you are 65 or older,
Slovenian: Če ste stari 65 let ali več, je to tveganje večje.
English: Mean ± SD
Slovenian: ± SD
English: All patients administered Flixabi are to be observed for at least 1-2 hours post-infusion for acute infusion-related reactions.
Slovenian: Vse bolnike, ki prejmejo zdravilo Flixabi, je treba opazovati najmanj 1 do 2 uri po infuziji zaradi akutnih z infuzijo povezanih reakcij.
English: Granulomatous lesion.
Slovenian: granulomatozne lezije
English: Patients who have inflammatory diseases already take medicines to treat their problem.
Slovenian: Bolniki z vnetnimi boleznimi že prejemajo zdravila za zdravljenje le-teh.
English: • This medicine can also be stored in the original carton outside of refrigerated storage up to a maximum of 25°C for a single period of up to six months.
Slovenian: • To zdravilo lahko shranjujete tudi v originalni škatli zunaj hladilnika pri temperaturi do 25 °C za eno obdobje do 6 mesecev.
English: • Inflammation in the eye that may cause changes in the vision, including blindness
Slovenian: • vnetje očesa, ki lahko povzroči spremembe vida, vključno s slepoto,
English: Keep this card with you for 4 months after your dose of Flixabi, or in case of pregnancy for at least 6 months after the birth of your baby.
Slovenian: To kartico nosite s seboj še 4 mesece po svojem odmerku zdravila Flixabi ali v primeru nosečnosti še vsaj 6 mesecev po rojstvu.
English: Interstitial lung disease (including rapidly progressive disease, lung fibrosis and pneumonitis).
Slovenian: intersticijska pljučna bolezen (vključno s hitro napredujočo boleznijo, pljučno fibrozo in pnevmonitisom)
English: Flixabi is also used in adults and children 6 years of age or older for:
Slovenian: Zdravilo Flixabi se uporablja tudi za zdravljenje odraslih in otrok, starih 6 let in več, za:
English: • Changes in how your liver works, increase in liver enzymes (shown in blood tests)
Slovenian: • spremenjeno delovanje vaših jeter, povečanje vrednosti jetrnih encimov (pokaže se v izvidih krvnih preiskav),
English: The new expiry date must be written on the carton.
Slovenian: Novi datum izteka roka uporabnosti morate napisati na škatlo.
English: Please make sure you also have a list of all other medicines that you are using with you at any visit to a healthcare professional.
Slovenian: Poskrbite, da boste ob vsakem obisku zdravstvenega delavca imeli s sabo tudi seznam vseh ostalih zdravil, ki jih uporabljate.
English: Flixabi should only be used during pregnancy if your doctor feels it is necessary for you.
Slovenian: Zdravilo Flixabi se lahko uporablja med nosečnostjo le, če zdravnik meni, da je to pri vas potrebno.
English: For women taking infliximab including those over 60 years of age, your doctor may recommend regular screening for cervical cancer.
Slovenian: Ženskam, ki prejemajo infliksimab, vključno s starejšimi od 60 let, lahko zdravnik priporoči redne presejalne teste za raka materničnega vratu.
English: Instructions for use and handling - reconstitution, dilution and administration In order to improve the traceability of biological medicinal products, the tradename and batch number of the administered medicinal product should be clearly recorded.
Slovenian: Navodila za uporabo in ravnanje z zdravilom - rekonstitucija, redčenje in infundiranje Zaradi izboljšanja sledljivosti bioloških zdravil morata biti jasno zabeležena lastniško ime in številka serije uporabljenega zdravila.
English: If you forget or miss your Flixabi infusion If you forget or miss an appointment to receive Flixabi, make another appointment as soon as possible.
Slovenian: Če ste pozabili ali izpustili odmerek zdravila Flixabi Če ste pozabili ali izpustili dogovorjen termin, da bi prejeli zdravilo Flixabi, se čim prej dogovorite za naslednjega.
English: Your doctor will test you to see if you have TB.
Slovenian: Zdravnik vas bo testiral, da bo ugotovil, ali imate tuberkulozo.
English: Key efficacy results for IMPACT and IMPACT 2 are shown in Table 9 below:
Slovenian: Ključni izsledki o učinkovitosti zdravila iz študij IMPACT in IMPACT 2 so prikazani v spodnji preglednici 9:
English: • Cancer in children and adults
Slovenian: • rak pri otrocih in odraslih,
English: From a microbiological point of view, the product should be used as soon as possible but within 3 hours of reconstitution and dilution.
Slovenian: Z mikrobiološkega stališča pa morate raztopino uporabiti čim prej, najpozneje pa v roku 3 ur po rekonstituciji in redčenju.
English: Flixabi will be stored by the health professionals at the hospital or clinic.
Slovenian: Za shranjevanje zdravila Flixabi bodo poskrbeli zdravstveni delavci v bolnišnici ali kliniki.
English: There have also been post-marketing reports of new onset heart failure, including heart failure in patients without known pre-existing cardiovascular disease.
Slovenian: Obstajajo tudi poročila iz obdobja trženja o novonastalem srčnem popuščanju, vključno s srčnim popuščanjem pri bolnikih brez znane predhodne srčno-žilne bolezni.
English: Flixabi may be stored at temperatures up to a maximum of 25°C for a single period of up to 6 months, but not exceeding the original expiry date.
Slovenian: Zdravilo Flixabi lahko shranjujete pri temperaturi do 25 °C za eno obdobje do 6 mesecev, vendar ne smete prekoračiti originalnega datuma izteka roka uporabnosti.
English: Early recognition of atypical clinical presentations of serious infections and of typical clinical presentation of rare and unusual infections is critical in order to minimise delays in diagnosis and treatment.
Slovenian: Bistvenega pomena je tudi zgodnja prepoznava atipičnih kliničnih slik resnih okužb in tipičnih kliničnih slik redkih in neobičajnih okužb, da bi lahko čim bolj zmanjšali zamude pri njihovi diagnozi in zdravljenju.
English: Experimental data show that TNFα is essential for the clearing of intracellular infections.
Slovenian: Eksperimentalni podatki kažejo, da je TNFα bistven za odpravljanje znotrajceličnih okužb.
English: Patients who did not respond to infliximab at week 8 (n=15) received no further medicinal product and returned for safety followup.
Slovenian: Bolniki, ki se do 8. tedna niso odzvali na infliksimab (n = 15), niso več prejemali zdravila in so se vrnili na kontrolni pregled glede varnosti.
English: • Difficult or painful breathing, chest pain
Slovenian: • težko ali boleče dihanje, bolečine v prsih,
English: This will depend on your disease, weight and how well you respond to Flixabi.
Slovenian: To bo odvisno od vaše bolezni, telesne mase in tega, kako se odzivate na zdravilo Flixabi.
English: For storage conditions up to 25°C before reconstitution of the medicinal product, see section 6.3.
Slovenian: Za navodila za shranjevanje pri temperaturi do 25 °C pred rekonstitucijo zdravila glejte poglavje 6.3.
English: Re-administration for Crohn's disease and rheumatoid arthritis If the signs and symptoms of disease recur, Flixabi can be re-administered within 16 weeks following the last infusion.
Slovenian: Ponovna uporaba zdravila pri Crohnovi bolezni in revmatoidnem artritisu Če se znaki in simptomi bolezni ponovijo, lahko zdravilo Flixabi ponovno uporabite v roku 16 tednov po zadnji infuziji.
English: If patients are re-treated after a prolonged period, they must be closely monitored for signs and symptoms of delayed hypersensitivity.
Slovenian: Če bolnik po daljšem obdobju ponovno prejme zdravilo, ga morate skrbno spremljati zaradi morebitnega pojava znakov in simptomov pozne preobčutljivosti.
English: Flixabi belongs to a group of medicines called ‘TNF blockers'.
Slovenian: Zdravilo Flixabi spada v skupino zdravil, ki se imenujejo "zaviralci TNF".
English: In vivo, infliximab rapidly forms stable complexes with human TNFα, a process that parallels the loss of TNFα bioactivity.
Slovenian: In vivo infliksimab hitro tvori stabilne komplekse s humanim TNFα, ta proces pa poteka vzporedno z izgubo biološke aktivnosti TNFα.
English: There have been reports of active tuberculosis in patients receiving infliximab.
Slovenian: Bilo je nekaj poročil o aktivni tuberkulozi pri bolnikih, ki so prejemali infliksimab.
English: • Flixabi will be given to you by your doctor or nurse.
Slovenian: • Zdravilo Flixabi vam bo dal zdravnik ali medicinska sestra.
English: Because human immunoglobulins are excreted in milk, women must not breast-feed for at least 6 months after Flixabi treatment.
Slovenian: Ker pa se človeški imunoglobulini izločajo v materino mleko, matere ne smejo dojiti še najmanj 6 mesecev po zdravljenju z zdravilom Flixabi.
English: b CDAI < 150 at both week 30 and 54 and not receiving corticosteroids in the 3 months prior to week 54 among patients who were receiving corticosteroids at baseline.
Slovenian: b CDAI < 150 tako v 30. tednu kot v 54. tednu, brez prejemanja kortikosteroidov v 3 mesecih pred 54. tednom pri bolnikih, ki so prejemali kortikosteroide na začetku študije.
English: 3 Number of patients evaluated for ALT.
Slovenian: 3 Število bolnikov, pri katerih so ovrednotili vrednost ALT.
English: Before reconstitution 4 years at 2°C - 8°C.
Slovenian: Pred rekonstitucijo: 4 leta pri temperaturi 2 °C-8 °C.
English: • Infections due to a weakened immune system
Slovenian: • okužbe zaradi oslabljenega imunskega sistema,
English: ≥ 50% improvement PGA of cleared (0) or minimal (1)
Slovenian: ≥ 50 % izboljšanje PGA brez plakov (0) ali minimalni (1)
English: What Flixabi is and what it is used for
Slovenian: Kaj je zdravilo Flixabi in za kaj ga uporabljamo
English: Subjects randomised Percentage ACR improvement Mean ± SD
Slovenian: Randomizirani preiskovanci Odstotek izboljšanja ACR Srednja vrednost ± SD
English: If not used immediately, in use storage times and conditions prior to use are the responsibility of the user and should not be longer than 24 hours at 2°C to 8°C.
Slovenian: Če raztopina ni uporabljena takoj, je za pogoje in čas shranjevanja pred uporabo odgovoren uporabnik, in le-to ne sme trajati dlje kot 24 ur pri temperaturi med 2 °C in 8 °C.
English: 4 Median follow-up is based on patients treated.
Slovenian: 4 Mediana dolžine spremljanja bolnikov je bila določena samo z upoštevanjem zdravljenih bolnikov.
English: 178 of the 580 enrolled patients (30.7%) were defined as having severe disease (CDAI score > 300 and concomitant corticosteroid and/or immunosuppressants) corresponding to the population defined in the indication (see section 4.1).
Slovenian: Pri 178 od 580 v študijo vključenih bolnikov (30,7 %) so ugotovili hudo obliko bolezni (ocena CDAI > 300 in sočasna uporaba kortikosteroidov in/ali imunosupresivov), kar ustreza populaciji, opredeljeni v indikacijah (glejte poglavje 4.1).
English: Infliximab + MTX
Slovenian: infliksimab + MTX
English: It is important that you tell your baby's doctors and other health care professionals about your Flixabi use so they can decide when your baby should receive any vaccine, including live vaccines such as BCG (used to prevent tuberculosis).
Slovenian: Pomembno je, da zdravnike svojega otroka in druge zdravstvene delavce obvestite, da ste prejemali zdravilo Flixabi, da bodo lahko presodili, kdaj sme vaš dojenček prejeti katero koli cepivo, vključno z živimi cepivi, kot je cepivo BCG (uporablja se za preprečevanje tuberkuloze).
English: (anaphylactic shock)
Slovenian: (anafilaktični šok),
English: • Melanoma (a type of skin cancer).
Slovenian: • melanom (vrsta kožnega raka),
English: Flixabi should only be used in children and adolescents if they are being treated for Crohn`s disease or ulcerative colitis.
Slovenian: Zdravilo Flixabi se sme pri otrocih in mladostnikih uporabljati samo za zdravljenje Crohnove bolezni ali ulceroznega kolitisa.
English: ACR 20 response* ACR 50 response* ACR 70 response* PASI response (% of patients)b
Slovenian: Odziv ACR (% bolnikov) N odziv ACR 20* odziv ACR 50* odziv ACR 70* Odziv PASI (% bolnikov)b
English: Acute infusion reactions including anaphylactic reactions may develop during (within seconds) or within a few hours following infusion.
Slovenian: Akutna z infuzijo povezana reakcija, vključno z anafilaktično reakcijo, lahko nastopi med infuzijo (t. j. v nekaj sekundah) ali v roku nekaj ur po infuziji.
English: • Low blood counts, including a severely decreased number of white blood cells.
Slovenian: • nizko število krvnih celic, vključno z močnim znižanjem števila belih krvnih celic.
English: If you feel tired, dizzy, or unwell after having Flixabi, do not drive or use any tools or machines.
Slovenian: Če se po prejemu zdravila Flixabi počutite utrujeni ali se ne počutite dobro, ne smete voziti ali upravljati kakršnih koli orodij ali strojev.
English: c HAQ = Health Assessment Questionnaire; greater values indicate less disability.
Slovenian: c HAQ = vprašalnik za oceno zdravstvenega stanja; večje vrednosti pomenijo manjšo okvaro funkcije.
English: What Flixabi is and what it is used for What you need to know before you use Flixabi How Flixabi will be given Possible side effects
Slovenian: Kaj je zdravilo Flixabi in za kaj ga uporabljamo Kaj morate vedeti, preden boste uporabili zdravilo Flixabi Kako uporabljati zdravilo Flixabi Možni neželeni učinki
English: • Treatment with TNF blockers such as Flixabi may result in reactivation of hepatitis B virus in patients who carry this virus, which can be life-threatening in some cases.
Slovenian: • Zdravljenje z zaviralci TNF, kot je zdravilo Flixabi, lahko vodi do reaktivacije virusa hepatitisa B pri bolnikih, ki prenašajo ta virus, kar je lahko v nekaterih primerih življenjsko nevarno.
English: N ≥ 90% improvement ≥ 75% improvement ≥ 50% improvement
Slovenian: 50. teden n ≥ 90 % izboljšanje ≥ 75 % izboljšanje ≥ 50 % izboljšanje
English: Flixabi may have a minor influence on the ability to drive and use machines.
Slovenian: Zdravilo Flixabi ima lahko blag vpliv na sposobnost vožnje in upravljanja strojev.
English: If inactive (‘latent') tuberculosis is diagnosed, treatment for latent tuberculosis must be started with antituberculosis therapy before the initiation of Flixabi, and in accordance with local recommendations.
Slovenian: V primeru diagnoze neaktivne (latentne) tuberkuloze morate uvesti zdravljenje za latentno tuberkulozo z antituberkulozno terapijo še pred uvedbo zdravila Flixabi, v skladu z lokalnimi priporočili.
English: Table 1 Undesirable effects in clinical studies and from post-marketing experience Infections and infestations Very Common:
Slovenian: Preglednica 1 Neželeni učinki v kliničnih študijah in v obdobju trženja zdravila Infekcijske in parazitske bolezni zelo pogosti:
English: However, studies from the published literature in various indications (e.g. rheumatoid arthritis, psoriasis, Crohn's disease) suggest that non-live vaccinations received during treatment with anti-TNF therapies, including infliximab, may elicit a lower immune response than in patients not receiving anti-TNF therapy.
Slovenian: Vseeno pa študije iz objavljene literature za različne indikacije (npr. revmatoidni artritis, psoriaza, Crohnova bolezen) nakazujejo, da cepljenja z neživimi cepivi med prejemanjem anti-TNF terapije, vključno z infliksimabom, lahko izzovejo manjši imunski odgovor kot pri bolnikih, ki ne prejemajo anti-TNF terapije.
English: • Hepatitis B infection when you have had hepatitis B in the past
Slovenian: • okužba s hepatitisom B, če ste ga že preboleli v preteklosti,
English: • Talk to your doctor if you have recently received or are scheduled to receive treatment with a therapeutic infectious agent (such as BCG instillation used for the treatment of cancer).
Slovenian: • Obvestite zdravnika, če ste pred kratkim prejeli ali boste prejeli povzročitelje okužb v terapevtske namene (kot je uporaba BCG za zdravljenje raka).
English: Telephone number doctor:
Slovenian: Telefon zdravnika:
English: Calculate the dose and the number of Flixabi vials needed.
Slovenian: Izračunajte odmerek in število potrebnih vial zdravila Flixabi.
English: • Psoriasis.
Slovenian: • psoriaza.
English: • Pain in the joints, muscles or back
Slovenian: • bolečine v sklepih, mišicah ali hrbtu,
English: • It is very important that you tell your doctor if you have ever had tuberculosis (TB), or if you have been in close contact with someone who has had TB.
Slovenian: • Zelo pomembno je, da zdravniku poveste, če ste kdaj imeli tuberkulozo (TBC) ali če ste bili v tesnem stiku s tuberkuloznim bolnikom.
English: The relative deficiency of TNFα caused by anti-TNF therapy may result in the initiation of an autoimmune process.
Slovenian: Relativno pomanjkanje TNFα kot posledica anti-TNF terapije lahko sproži avtoimunski proces.
English: Store in a refrigerator Can be stored at room temperature (up to 25°C) for a single period up to 6 months.
Slovenian: Lahko shranjujete pri sobni temperaturi (do 25 °C) za eno obdobje do 6 mesecev.
English: There are no known side effects of having too much of Flixabi.
Slovenian: Ni poznanih neželenih učinkov zaradi prejetja prevelikega odmerka zdravila Flixabi.
English: If you received Flixabi while pregnant, giving BCG vaccine (used to prevent tuberculosis) to your baby within 6 months after birth may result in infection with serious complications, including death.
Slovenian: Če ste v času nosečnosti prejeli zdravilo Flixabi, lahko cepljenje dojenčka s cepivom BCG (uporablja se za preprečevanje tuberkuloze) v obdobju 6 mesecev po rojstvu povzroči okužbo z resnimi zapleti, vključno s smrtjo.
English: The potential risk with the combination of AZA or 6-MP and Flixabi should be carefully considered.
Slovenian: Natančno je treba pretehtati potencialno tveganje pri sočasnem dajanju AZA ali 6-MP z zdravilom Flixabi.
English: Studies in mice deficient in TNFα demonstrated no increase in tumours when challenged with known tumour initiators and/or promoters.
Slovenian: Študije pri miših s pomanjkanjem TNFα niso pokazale povečanja pogostnosti tumorjev po provokaciji z znanimi sprožilci novih tumorjev in/ali spodbujevalci.
English: • Worsening of a condition called dermatomyositis (seen as a skin rash accompanying muscle weakness)
Slovenian: • poslabšanje dermatomiozitisa (ki se kaže kot kožni izpuščaj, ki spremlja šibkost mišic),
English: Specific studies of infliximab in elderly patients have not been conducted.
Slovenian: Specifične študije infliksimaba pri starejših bolnikih niso bile izvedene.
English: Since the possibility of increased risk of cancer development in patients with newly diagnosed dysplasia treated with infliximab is not established, the risk and benefits of continued therapy to the individual patients should be carefully considered by the clinician.
Slovenian: Ker verjetnost povečanega tveganja za nastanek karcinoma pri bolnikih z novo diagnosticirano displazijo, ki se zdravijo z infliksimabom, ni ugotovljena, mora zdravnik skrbno pretehtati tveganje in koristi nadaljevanja zdravljenja za posameznega bolnika.
English: Placebo (week 16)
Slovenian: placebo (16. teden)
English: ≥ 5 x ULN placebo infliximab placebo infliximab placebo infliximab placebo infliximab
Slovenian: placebo infliksima b placebo infliksimab placebo infliksimab placebo infliksimab
English: Table 4 Effects on ACRn, Structural Joint Damage and Physical Function at week 54, ASPIRE
Slovenian: Preglednica 4 Učinki na ACRn, strukturno poškodbo sklepov in funkcijo sklepov v 54. tednu, ASPIRE
English: Invasive fungal infections may present as disseminated rather than localised disease, and antigen and antibody testing may be negative in some patients with active infection.
Slovenian: Invazivne glivične okužbe lahko namesto v obliki lokalizirane nastopajo v obliki razsejane bolezni, poleg tega pa sta lahko pri nekaterih bolnikih z aktivno okužbo testa na antigen in protitelesa negativna.
English: Flixabi must be given concomitantly with methotrexate.
Slovenian: Zdravilo Flixabi morate uporabljati sočasno z metotreksatom.
English: • Collections of immune cells resulting from an inflammatory response (granulomatous lesions)
Slovenian: • kopičenje imunskih celic zaradi vnetnega odziva (granulomatozne lezije),
English: • A reminder to patients to show the patient reminder card to all treating HCPs, including in conditions of emergency, and a message for HCPs that the patient is using Flixabi
Slovenian: • Opomnik za bolnike, da morajo pokazati opozorilno kartico za bolnika vsem zdravstvenim delavcem, ki sodelujejo pri zdravljenju (tudi v nujnih stanjih) ter sporočilo za zdravstvene delavce, da bolnik uporablja zdravilo Flixabi.
English: In all situations described below, the benefit/risk balance of Flixabi therapy should be very carefully considered.
Slovenian: V vseh spodaj opisanih okoliščinah je treba zelo skrbno pretehtati razmerje med koristmi in tveganji zdravljenja z zdravilom Flixabi.
English: Available data suggest an increased risk for delayed hypersensitivity with increasing infliximab-free interval.
Slovenian: Podatki, ki so na voljo, kažejo povečano tveganje za pozno preobčutljivost pri povečevanju premora brez prejemanja infliksimaba.
English: • Tell your doctor if you have had treatment with medicines containing infliximab in the past and are now starting Flixabi treatment again.
Slovenian: • Povejte zdravniku, če ste se v preteklosti že zdravili z zdravili, ki vsebujejo infliksimab, in sedaj ponovno začenjate zdravljenje z zdravilom Flixabi.